NEW YORK — Patients with rheumatoid arthritis (RA) carry a high risk for cardiovascular events, but mounting clinical evidence suggests they're being undertreated to manage that risk. Rheumatologists ...

Cedars-Sinai’s center provides personalized, multidisciplinary care for RA and related conditions, improving patient outcomes and quality of life. Dr. Jon Giles' research explores autoimmune disease ...

Germany: A real-world prospective cohort study published in RMD Open: Rheumatic & Musculoskeletal Diseases suggests that ...

Announcing a new article publication for BIO Integration journal. In recent years, phytochemicals and medicinal plants have ...

In a real-world, prospective study, upadacitinib demonstrated great potential for the treatment of rheumatoid arthritis (RA) regardless of a patient’s baseline C-reactive protein (CRP) levels.

Editor’s note: This is an automatically generated transcript. Please notify editor@healio.com if there are concerns regarding accuracy of the transcription. Certainly we've learned a lot about JAK ...

Announcing a new publication for Acta Materia Medica journal. Diacerein, an anthraquinone derivative, is emerging as a ...

Functional MRI studies have established that subjective feelings of pain and fatigue have objective correlates in terms of neuronal activity patterns. This study sought to determine whether neural ...

Please provide your email address to receive an email when new articles are posted on . Peresolimab was beneficial for patients with rheumatoid arthritis, compared with placebo, in a phase 2a study.

Whether you are seeking information for yourself or a loved one, read on to learn more about the disease and how to better understand its signs and symptoms. Rheumatoid arthritis is an inflammatory ...

Rheumatoid arthritis (RA) may cause inflammation in your eyes, leading to complications such as dry eyes, redness, and floaters, among others. Early treatment may prevent these conditions from ...